Faeth Therapeutics (FTH) Other financing activities (2021 - 2026)
Faeth Therapeutics' (FTH) quarterly Other financing activities came in at $1.0 million in Q1 2026, up 334.03% on a QoQ basis from $238000.0 in Q1 2022.
Faeth Therapeutics (FTH) Other financing activities (2021 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 3 years of Other financing activities data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (changed N/A YoY) and the FY2025 annual result came in at $2000.0, changed N/A from the prior year.
- Other financing activities grew to $1.0 million in Q1 2026, from $238000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.0 million in Q1 2026 to a low of $238000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Faeth Therapeutics | 184.08 Mn | 184.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 98,000.00 |
| Jun 30, 2026 | 98,000.00 |
| Mar 31, 2026 | 1.03 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Mar 31, 2022 | 238,000.00 |
| Mar 31, 2022 | 238,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |